ClinVar Miner

Submissions for variant NM_001127222.2(CACNA1A):c.2133C>G (p.Ile711Met)

dbSNP: rs764839814
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000519829 SCV000618721 likely pathogenic not provided 2017-11-30 criteria provided, single submitter clinical testing The I712M variant in the CACNA1A gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The I712M variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The I712M variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. A different missense variant in the same residue (I712V) has been reported as heterozygous de novo in a female with seizures, ataxia, headaches, developmental regression, intellectual disability, and mild cerebellar atrophy (Guerin et al., 2008). In addition, missense variants in nearby residues (A713T, V714A, D715E) have been reported in the Human Gene Mutation Database in association with CACNA1A-related disorders (Stenson et al., 2014), supporting the functional importance of this region of the protein. We interpret I712M as a likely pathogenic variant.
Invitae RCV001853632 SCV002208573 uncertain significance Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 2020-12-30 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CACNA1A protein function. This variant has not been reported in the literature in individuals with CACNA1A-related conditions. ClinVar contains an entry for this variant (Variation ID: 450171). This variant is not present in population databases (ExAC no frequency). This sequence change replaces isoleucine with methionine at codon 712 of the CACNA1A protein (p.Ile712Met). The isoleucine residue is highly conserved and there is a small physicochemical difference between isoleucine and methionine.
Wendy Chung Laboratory, Columbia University Medical Center RCV002227178 SCV002506539 likely pathogenic Episodic ataxia type 2; Spinocerebellar ataxia type 6; Migraine, familial hemiplegic, 1; Developmental and epileptic encephalopathy, 52 2022-03-20 criteria provided, single submitter clinical testing
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology RCV003492089 SCV004232712 likely pathogenic Episodic ataxia type 2; Spinocerebellar ataxia type 6; Migraine, familial hemiplegic, 1; Developmental and epileptic encephalopathy, 42 2023-12-14 criteria provided, single submitter research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.